For an FQHC CEO, CFO, 340B program director, or board member, the most important 340B question is not simply, “How much did we save?”

It is:

What did those savings make possible for the patients and communities we serve?

The 340B Drug Pricing Program was created to help eligible safety-net providers stretch scarce federal resources. Through ceiling-price discounts on covered outpatient drugs, participating manufacturers and covered entities support a model that can improve access to care, reduce medication costs, and strengthen services for underserved populations.

But the opportunity also creates a responsibility. Your entity must be able to explain how 340B savings are generated, how they support your mission, and how your methodology and documentation withstand regulatory, legislative, and public scrutiny.

What Are 340B Savings?

Under Section 340B of the Public Health Service Act, eligible covered entities may purchase certain outpatient drugs at prices that do not exceed the statutory 340B ceiling price.[^1]

The ceiling price is generally calculated using the Average Manufacturer Price and the Unit Rebate Amount:

340B ceiling price = Average Manufacturer Price − Unit Rebate Amount

The resulting discount allows your entity to acquire eligible medications for less than it might pay through a conventional purchasing arrangement.

The difference between acquisition cost and reimbursement: or the amount your entity chooses to discount for an uninsured patient: creates the economic value commonly called 340B savings.

However, it is important to use precise language:

Gross savings are the difference between a standard benchmark price and the 340B acquisition price.
Program income or margin is the amount remaining after reimbursement, dispensing costs, pharmacy fees, administrative expenses, bad debt, and other relevant costs.
Net savings available for mission investment should be calculated using a consistent, documented methodology.

That distinction matters. A board report showing gross theoretical savings is not the same as a report showing cash actually available to support patient care.

The Mission Multiplier: Where Covered Entities Invest Savings

340B savings can act as a mission multiplier. They help your organization serve more patients, offer more services, and address barriers that often prevent people from receiving care.

The exact use of savings differs by entity type, governing structure, grant requirements, and financial model. For FQHCs and other safety-net organizations, common mission-driven uses include the following.

1. Expanding Access to Care

Savings can help your entity extend access beyond the traditional clinic schedule or service footprint.

Examples include:

Adding evening or weekend appointments.
Opening a new primary care location.
Expanding same-day or walk-in services.
Supporting mobile health units.
Increasing appointment capacity in high-demand specialties.
Serving patients in rural or medically underserved areas.

For example, an FQHC may use additional program income to support a satellite clinic in a community where residents face long travel times to receive primary care. The value is not only the number of prescriptions processed. It is the new point of access created for patients who previously delayed care.

2. Supporting Uninsured and Underinsured Patients

Many patients face difficult choices between medication, rent, food, and transportation. A covered entity may use savings to make treatment more affordable through:

Free or discounted medications.
Patient assistance programs.
Copay support.
Medication synchronization and adherence services.
Financial counseling.
Enrollment assistance for Medicaid, Medicare, or marketplace coverage.
Assistance for patients who do not qualify for insurance but cannot afford treatment.

A practical example is a pharmacy team identifying a patient who repeatedly abandons prescriptions because of cost. A structured assistance program can reduce the financial barrier, while medication counseling and follow-up improve the likelihood that the patient continues treatment.

Your public explanation should describe the process without exposing protected health information. The goal is to show how the program supports access while preserving patient privacy.

3. Strengthening Sliding Fee Scales

FQHCs commonly use sliding fee discounts to reduce charges based on household income and family size. 340B-supported resources can help sustain this approach.

Savings may support:

Deeper discounts for qualifying patients.
Administrative staff who verify eligibility.
Patient communication about available assistance.
Financial counseling and enrollment support.
Technology that helps apply discounts consistently.

A sliding fee scale is not merely a billing policy. It is an access tool. When your organization can apply it accurately and explain it clearly, more patients are likely to seek care before a manageable condition becomes a crisis.

4. Expanding Dental and Behavioral Health Services

Dental and behavioral health needs are often significant, yet these services may be difficult for low-income patients to access.

Covered entities may use mission-supported resources to add:

Dental operatories and equipment.
Dental hygienists, assistants, and dentists.
Behavioral health counselors.
Psychiatric consultation.
Substance use disorder treatment.
Integrated care coordinators.
Screening and referral programs.

This is one of the clearest examples of how 340B savings can support whole-person care. A patient who visits for diabetes management may also receive a behavioral health screening, oral health referral, or assistance addressing transportation and food insecurity.

Healthcare consultants reviewing 340B strategy, compliance documentation, and community-focused program performance

5. Removing Transportation and Outreach Barriers

Access depends on more than whether a clinic has an appointment available. Patients may lack transportation, childcare, internet access, or trust in the healthcare system.

Savings can support:

Transportation assistance.
Community health workers.
Patient navigators.
Language interpretation.
Outreach events.
Health education.
Home-based services.
Partnerships with shelters, schools, food banks, and community organizations.

For instance, a health center may fund a navigator who helps patients complete insurance applications, schedule follow-up visits, arrange transportation, and understand medication instructions. That role can connect multiple services that would otherwise remain fragmented.

6. Investing in Telehealth and Digital Access

Telehealth can extend care to patients who cannot easily travel. Covered entities may direct resources toward:

Telehealth platforms.
Remote patient monitoring.
Digital check-in tools.
Patient portal support.
Broadband or device assistance.
Staff training.
Virtual behavioral health appointments.

Telehealth is not a universal solution. Some patients need in-person examinations, laboratory services, or physical support. But when it is designed around patient needs, it can reduce missed appointments and make follow-up care more practical.

7. Hiring and Retaining the Right Staff

A sustainable mission requires people. Savings may support staffing in areas such as:

Pharmacists and pharmacy technicians.
Care coordinators.
Nurses and medical assistants.
Compliance specialists.
Data analysts.
Revenue-cycle personnel.
Community health workers.
Quality improvement staff.

Staffing investments can improve operational reliability and patient experience at the same time. They can also strengthen 340B oversight by ensuring that eligibility, purchasing, dispensing, billing, and reconciliation workflows have accountable owners.

8. Building Infrastructure and New Service Lines

Some of the most consequential investments are long-term.

Examples include:

Launching or expanding an entity-owned pharmacy.
Upgrading pharmacy technology.
Improving medication inventory controls.
Adding specialty-care capabilities.
Developing chronic disease programs.
Expanding laboratory or diagnostic services.
Renovating clinical space.
Implementing analytics and reporting systems.

An in-house pharmacy, for example, may give an FQHC greater control over patient access, medication counseling, inventory, and data. The right model depends on volume, staffing, payer mix, geography, regulatory requirements, and financial projections.

GapRx supports entities evaluating and managing these opportunities through 340B In-House Pharmacy Management and 340B Analytics & Program Dashboards.

The Growing Scrutiny: Your Story Must Be Defensible

340B has become a focus of congressional debate, manufacturer policy changes, payer disputes, media coverage, and proposed legislation. The question of how covered entities use savings is increasingly part of that conversation.

That creates a serious risk: your organization may be doing meaningful work but lack the documentation to explain it.

A strong mission narrative should answer five questions:

How were savings calculated?
What costs were deducted to determine net savings or program income?
Which services or patient-support activities received investment?
What outcomes or operational improvements resulted?
What controls ensure the program remains compliant?

Do not rely on vague statements such as “340B supports our mission.” Explain the connection. For example:

“Our pharmacy program helped fund medication assistance, care-navigation staff, and expanded behavioral health access for patients who face financial and transportation barriers.”

That statement is more credible when supported by board-approved policies, financial reports, program budgets, service-line documentation, and outcome measures.

Document Savings Usage With the “MISSION” Framework

Your entity can use the following framework to organize reporting:

M : Methodology: Define how gross savings, expenses, and net program income are calculated.
I : Investment plan: Identify the services, staff, infrastructure, or patient assistance programs supported.
S : Safeguards: Document controls for diversion, duplicate discounts, patient eligibility, and vendor oversight.
S : Story: Translate financial activity into a clear community-impact narrative.
I : Indicators: Track meaningful measures such as access, medication assistance, visits, staffing, or service capacity.
O : Oversight: Provide executive and board-level review.
N : Narrative reporting: Prepare consistent annual and public-facing explanations.

This framework is especially useful as proposed reforms evolve. The SECURE 340B Act vs. SUSTAIN 340B Act comparison discusses how potential changes could increase reporting, executive accountability, audits, and documentation expectations.

The details of any proposal can change, and neither framework should be treated as enacted law unless and until Congress passes legislation and applicable agencies issue guidance. Still, preparing now is prudent.

Healthcare professional reviewing 340B savings, compliance, and program performance analytics on a digital dashboard

Build the Controls Behind the Story

A compelling community-impact report cannot compensate for weak program controls.

Your organization should maintain:

Written policies and procedures.
A defined 340B governance structure.
Documented pharmacy and TPA oversight.
Claim-level eligibility and diversion controls.
Duplicate-discount monitoring.
Reconciliation between pharmacy, claims, finance, and general-ledger data.
Routine internal audits.
Corrective-action documentation.
Staff education.
Executive attestations where required or adopted by policy.

Review Building a 340B Compliance Team for Audit Readiness for a practical governance structure. GapRx also provides HRSA Audit & 340B Compliance support to help covered entities assess policies, test controls, and prepare documentation.

Turning Savings Into Community Strength

340B savings are not an end in themselves. They are a mechanism that can help your organization expand access, reduce medication barriers, support staff, build infrastructure, and respond to community needs.

The strongest covered entities treat savings usage as both a financial discipline and a mission obligation. They calculate savings consistently. They monitor where resources go. They involve leadership and the board. They communicate outcomes in clear, patient-centered language. And they maintain the evidence needed to support every material claim.

If your entity cannot clearly connect its 340B performance to patient access and community benefit, now is the time to improve that connection.

Schedule a 30-minute 340B strategy call with GapRx to discuss savings methodology, reporting, compliance, pharmacy operations, and mission-focused program optimization.

Disclaimer: This article is for informational and educational purposes only. It is not legal, accounting, regulatory, or compliance advice. Covered entities should consult qualified legal counsel, accountants, compliance professionals, and applicable federal or state authorities regarding their specific 340B obligations and savings-use policies.

Beyond the Bottom Line: How Covered Entities Use 340B Savings to Serve Their Communities